USAMMDA Commercial Partner Receives FDA Emergency Use Authorization for Plasma Powder

FORT DETRICK, Md. — A U.S. Army Medical Materiel Development Activity commercial partner received Emergency Use Authorization from the U.S. Food and Drug Administration for the Department of Defense to use octaplasLG Powder — a potentially lifesaving treatment option for blood replacement therapies in certain operational circumstances. Notice of the EUA for this product was […]

https://soldiersystems.net/2024/08/31/usammda-commercial-partner-receives-fda-emergency-use-authorization-for-plasma-powder/?utm_source=rss&utm_medium=rss&utm_campaign=usammda-commercial-partner-receives-fda-emergency-use-authorization-for-plasma-powder